You will not be allowed to compare more than 4 products at a time
View compareDescription
ColonLife
Description
Food for special medical purposes, indicated for the dietary treatment of colonopathies with altered mucosal trophism.
The combination of specific patented probiotics promotes the restoration and balance of the intestinal bacterial flora and provides added value in interpreting the integrative, sequential use of butyric acid and probiotics.
Ingredients
Tablets: Calcium butyrate, microcrystalline cellulose, hydroxypropylmethylcellulose, grapefruit seed powder dry extract (Citrus x paradisi Macfad), Eudraguard Biotic (E 1207), glycerol dibehenate, talc, vegetable magnesium stearate F.U., triethyl citrate (E 1505).
Capsules: Fructo-oligosaccharides, Bifidobacterium breve BR03 (DSM 16604), Lactobacillus plantarum LP01 (LMG P-21021), Lactobacillus reuteri LRE02 (DSM 23878); capsule: hydroxypropylmethylcellulose (HPMC).
Gluten-free.
Lactose-free.
Nutritional characteristics
Tablets
Capsules
Instructions for use
The use of ColonLife must always be supported, including the methods of use, only by the attending physician.
Sequential therapy is suggested, taking 1 tablet in the morning for the first ten days and 1 capsule in the morning for the subsequent ten days, unless otherwise indicated by medical advice.
The therapy can last between 2 and 12 months, according to medical indications.
It is advisable to take the tablets and capsules separately, away from meals, and always according to medical advice.
Warnings
Since ColonLife, as a food for special medical purposes, contains butyric acid in its overall formulation, an ingredient recommended for colon affections, it should not be used for other and different dietary supplementation needs.
The product cannot be used as the sole form of nourishment.
ColonLife must be used and taken with specific advice, methods of use, and control of the attending physician.
Indicated for the dietary regimen of people suffering from colonopathies with altered mucosal trophism.
Keep out of reach of children.
Storage
Store preferably in a cool and dry place.
Shelf life with intact packaging: 24 months.
Format
Box of 10 tablets + 10 capsules
Code. EUPH0044
Food for special medical purposes, indicated for the dietary treatment of colonopathies with altered mucosal trophism.
The combination of specific patented probiotics promotes the restoration and balance of the intestinal bacterial flora and provides added value in interpreting the integrative, sequential use of butyric acid and probiotics.
Ingredients
Tablets: Calcium butyrate, microcrystalline cellulose, hydroxypropylmethylcellulose, grapefruit seed powder dry extract (Citrus x paradisi Macfad), Eudraguard Biotic (E 1207), glycerol dibehenate, talc, vegetable magnesium stearate F.U., triethyl citrate (E 1505).
Capsules: Fructo-oligosaccharides, Bifidobacterium breve BR03 (DSM 16604), Lactobacillus plantarum LP01 (LMG P-21021), Lactobacillus reuteri LRE02 (DSM 23878); capsule: hydroxypropylmethylcellulose (HPMC).
Gluten-free.
Lactose-free.
Nutritional characteristics
Tablets
| Average values | per 1 tablet | per 100 g |
| Energy | 22.0 kJ 5.4 kcal |
2,097 kJ 512 kcal |
| Proteins | 0 mg | 0 g |
| Fats of which saturated |
523 mg 523 mg |
49.8 g 49.8 g |
| Carbohydrates of which sugars |
0 mg 0 mg |
0 g 0 g |
| Fibre | 333 mg | 31.7 g |
| Salt | 0 mg | 0 g |
| Calcium butyrate butyric acid intake |
614 mg 500 mg |
58.5 g 47.6 g |
| Grapefruit seed powder dry extract | 50 mg | 4.8 g |
Capsules
| Average values | per 1 capsule | per 100 g |
| Energy | 3.49 kJ 0.82 kcal |
982 kJ 231 kcal |
| Proteins | 10 mg | 2 g |
| Fats of which saturated |
1 mg 1 mg |
0.33 g 0.33 g |
| Carbohydrates of which sugars |
42 mg 23 mg |
11.7 g 6.5 g |
| Salt | 0.3 mg | 0.1 g |
| Fructo-oligosaccharides (FOS) | 236 mg | 66.5 g |
| Bifidobacterium breve BR03 | 2 billion cells | 563 billion cells |
| Lactobacillus plantarum LP01 | 1 billion cells | 282 billion cells |
| Lactobacillus reuteri LRE02 | 0.2 billion cells | 56 billion cells |
Instructions for use
The use of ColonLife must always be supported, including the methods of use, only by the attending physician.
Sequential therapy is suggested, taking 1 tablet in the morning for the first ten days and 1 capsule in the morning for the subsequent ten days, unless otherwise indicated by medical advice.
The therapy can last between 2 and 12 months, according to medical indications.
It is advisable to take the tablets and capsules separately, away from meals, and always according to medical advice.
Warnings
Since ColonLife, as a food for special medical purposes, contains butyric acid in its overall formulation, an ingredient recommended for colon affections, it should not be used for other and different dietary supplementation needs.
The product cannot be used as the sole form of nourishment.
ColonLife must be used and taken with specific advice, methods of use, and control of the attending physician.
Indicated for the dietary regimen of people suffering from colonopathies with altered mucosal trophism.
Keep out of reach of children.
Storage
Store preferably in a cool and dry place.
Shelf life with intact packaging: 24 months.
Format
Box of 10 tablets + 10 capsules
Code. EUPH0044

